Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 48 for “"PBPK modeling"”.
-
Physiologically-Based Pharmacokinetic (PBPK) Modeling for the Preclinical Development of Spectinamide Antibiotics
… used a physiologically-based pharmacokinetic (PBPK) approach for the prediction of drug pharmacokinetics in organs/tissues of interest and extrapolate their disposition across different species. In the current study, we built, qualified, and refined a minimalistic PBPK model that can describe …
-
Mechanistic Physiologically Based Pharmacokinetic (PBPK) Modeling of Renal and Systemic Disposition of Drugs and Metabolites
Physiologically-based pharmacokinetic (PBPK) models integrate system specific anatomy and physiology information with drug specific physicochemical and pharmacokinetic properties to predict drug disposition. Such integration permits items, events, processes, and pathways to communicate and …
-
Predicting Human Fetal Drug Exposure to Placental P-glycoprotein Substrates by PBPK Modeling and Simulation
… like physiologically-based pharmacokinetic (PBPK) modeling can be employed to predict (rather than measure) fetal drug exposure throughout pregnancy. We previously developed and verified a maternal-fetal (m-f) PBPK model that can successfully predict maternal and fetal exposure at term to …
-
Pediatric Physiologically Based Pharmacokinetic (PBPK) Modeling to Advance Knowledge of Breastfeeding Infant Exposure to Maternal Medications
… plasma. Physiologically based pharmacokinetic (PBPK) modeling is a promising tool to fill in the gap of scant maternal medication exposure information in breastfeeding infants. PBPK models use a simulation-based approach to model drug kinetics in an organism using knowledge of anatomy and …
-
Consequences of a lack of adult intravenous data on the prediction accuracy of pediatric physiologically based pharmacokinetic (PBPK) modeling
… used physiologically-based pharmacokinetic (PBPK) models as a means to efficiently plan pediatric clinical studies. PBPK models are mechanistic in nature and mathematically describe the disposition of drugs in an organism. This in silico technique predicts pharmacokinetic (PK) profiles based …
-
Investigating the role of drug transporters in furosemide absorption, food-effect and elimination by a proteomics informed-mechanistic PBPK modeling approach
… physiologically based pharmacokinetic (PBPK) modeling. Our in vitro results confirmed that furosemide is a substrate of various intestinal transporters, i.e., BCRP, MRP4 and OATP2B1. The PBPK model suggests that fasting condition leads to saturation of BCRP because of the faster gastric …
-
Predicting maternal-fetal cannabinoid exposure during pregnancy using physiologically-based pharmacokinetic modeling and simulation
… unethical. Physiological-based pharmacokinetic (PBPK) modeling and simulation can be used to predict drug exposure in silico. PBPK modeling incorporates physiological data, such as tissue composition and blood flows, with drug specific pharmacokinetic (PK) parameters, such as metabolism and …
-
Development and Application of Mechanistic IVIVE-Based Physiologically Based Pharmacokinetic (PBPK) Models for Predicting Drug Disposition: Case Studies of Miltefosine, Genistein, and PFOA
Physiologically based pharmacokinetic (PBPK) modeling, although first introduced in 1937, has since evolved into an indispensable tool for predicting drug disposition across species by integrating in vitro and in vivo data within a mathematical mechanistic framework. This approach facilitates a …
-
Development of a correlation based and a decision tree based prediction algorithm for tissue to plasma partition coefficients
Physiologically based pharmacokinetic (PBPK) modeling is a tool used in drug discovery and human health risk assessment. PBPK models are mathematical representations of the anatomy, physiology and biochemistry of an organism. PBPK models, using both compound and physiologic inputs, are used to …
-
An oral physiologically-based pharmacokinetic model to predict drug absorption and disposition of vismodegib
… tool is physiologically-based pharmacokinetic (PBPK) modeling, which integrates physiology with the physicochemical properties of a compound to simulate a concentration-time profile. This powerful tool is complex and most commonly applied in later stages of development, whereas early-stage …
-
Approaches to understanding antiretroviral pharmacology in difficult-to-access tissues for HIV treatment and prevention.
… with a physiologically based pharmacokinetic (PBPK) modeling approach.The study analyzed postmortem tissues collected from decedents with HIV who were on antiretroviral therapy. In chapter 2, the concentration and tissue-to-plasma penetration ratios of four antiretroviral drugs in 13 brain …
-
Evaluation of different in vitro surrogates to represent nonspecific binding for tissue: plasma water partition coefficient predictions
… use of physiologically-based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of a drug, accurate prediction of the tissue: plasma water partition coefficients (Kp,m) has become increasingly important. In these predictions, drug-lipid interactions have been traditionally …
-
Systems Pharmacokinetic Modeling of Antibody-Based Therapeutics
… and hence efficacy. For decades, systems PK modeling has served as a powerful tool to investigate factors governing in vivo disposition of therapeutics. As next-generation antibody therapeutics with diverse physicochemical properties and mechanisms of action surge, this dissertation seeks to …
-
Mechanistic modeling of alpha-synuclein aggregation and brain pharmacokinetics for drug development in neurodegeneration
Mechanistic modeling plays an increasingly important role in central nervous system (CNS) drug development, but its impact depends on how well models reflect the underlying biology and account for the limitations of available data. This thesis addresses these challenges through two distinct yet …
-
Bridging gaps between in vitro and in vivo data in pulmonary aerosol delivery with focus on pharmacokinetics
… further combined with physiological-based PK (PBPK) modeling to predict the PK profile of CsA and Ptx (e.g. maximum drug concentration cmax in the blood; time until cmax is reached (tmax)) after inhalation. This confirmed that cmax levels after inhalation were achieved fast (< 0.25 h). …
-
USING SEMIPHYSIOLOGICALLY-BASED PHARMACOKINETIC (SEMI-PBPK) MODELING TO EXPLORE THE IMPACT OF DIFFERENCES BETWEEN THE INTRAVENOUS (IV) AND ORAL (PO) ROUTE OF ADMINISTRATION ON THE MAGNITUDE AND TIME COURSE OF CYP3A-MEDIATED METABOLIC DRUG-DRUG INTERACTIONS (DDI) USING MIDAZOLAM (MDZ) AS PROTOTYPICAL SUBSTRATE AND FLUCONAZOLE (FLZ) AND ERYTHROMYCIN (ERY) AS PROTOTYPICAL INHIBITORS
… their inhibitory metabolic DDI. Individual semi-PBPK models for MDZ, FLZ and ERY were developed and validated separately, using pharmacokinetic (PK) parameters from clinical/in-vitro studies and published physiological parameters. Subsequently, DDI sub-models between MDZ and CYP3AIs incorporated …
-
Parameterization of In Silico Oral Disposition Models: Focus on Pediatrics
… design, physiologically-based pharmacokinetic (PBPK) models require quantitative knowledge of organism anatomy and physiology to facilitate appropriate parameterization. Within such models, an intrinsic relationship exists between the quality of input parameters and the confidence bestowed upon …
-
THE INTERPRETATION OF ITALIAN BREAST MILK MONITORING OF DIOXIN-LIKE AND NON-DIOXIN LIKE POLLUTANTS WITH A PBPK MODEL INTEGRATING A NOVEL APPROACH TO DESCRIBE PRE- AND POSTNATAL MOTHER/CHILD TRANSFER
… Italian non-occupationally exposed mothers by a PBPK model of mother and infant. Measurements included detection of 2,3,7,8 substituted polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and polychlorinated biphenyls and estimation of the dietary intake of these pollutants by …
-
Development of a Framework for Identifying Critical Input Parameters for Effective Pediatric PBPK/PBTK Modelling
Within a physiologically based pharmacokinetic (PBPK) model framework, virtual children are built based on known trajectories of anatomy and physiology across age and a compounds transfer within the body is defined by physicochemical and biochemical properties. Pediatric PBPK models have been used …
-
Dynamic Transport of Magnetic Driven Nanocarriers for Brain-Specific Drug Delivery
… Physiologically based pharmacokinetic (PBPK) modeling is further developed to explore the biodistribution of intraperitoneal (IP) injected of superparamagnetic iron oxide nanoparticles coated by gold and conjugated with poly (ethylene glycol) (PEG) (SPIO-Au-PEG NPs) in mice. In vivo …
Page 1 of 3